Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804

The Journal of Clinical Endocrinology and Metabolism
Francesca LombardoSebastiano Filetti

Abstract

Sixty-one heterozygotes harboring the germline V804L mutation of the RET protooncogene were identified in five independent families. A total of 31 subjects underwent surgery. Histology identified C cell hyperplasia in 30 cases, isolated in 12 and associated with medullary thyroid carcinoma (MTC) in 18. Six patients with MTC had lymph node metastases. Among the 14 patients with basal detectable calcitonin (CT) level, 12 had MTC and 2 had isolated C cell hyperplasia. In most individuals carrying 804 RET mutation, C cell disease displayed late onset and an indolent course; a pentagastrin test was negative in the majority of heterozygotes during the first 2 decades and was positive in only half of them during the third and fourth decades of life. Interestingly, concomitant somatic M918T was detected in a 12-yr-old girl with MTC and was likely to be responsible for both the early clinical appearance and the aggressiveness of the disease. Our data show that in these gene carriers, surgery may be postponed to the fourth decade of life or until the pentagastrin stimulation test becomes positive. Indeed, our data should be confirmed on a larger series of V804L carriers, but may offer a balanced strategy to keep under control and prevent...Continue Reading

References

May 13, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·P MottéD Bellet
Dec 1, 1982·The Journal of Pediatrics·R F GagelA H Tashjian
Sep 29, 1994·The New England Journal of Medicine·C J LipsM J Berends
May 11, 1999·JAMA : the Journal of the American Medical Association·O NilssonC Eng
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Eng
Sep 15, 1999·The Journal of Pediatrics·R A HeptullaM Genel
May 29, 2000·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·D K BartschW Höppner
Dec 15, 2000·Oncogene·S M Jhiang
Mar 31, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·E ChiefariM Zingrillo
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·P Niccoli-SireUNKNOWN French Calcitonin Tumors Group (GETC)

❮ Previous
Next ❯

Citations

May 19, 2006·BMC Cancer·Christian A KochRalf Paschke
Jun 17, 2011·Endocrine·Sandra MastroiannoSebastiano Filetti
May 27, 2008·Endocrinology and Metabolism Clinics of North America·Camilo JiménezRobert F Gagel
Aug 8, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Antonella VerrientiRocco Bruno
Jun 21, 2011·Head & Neck·Hélène BihanUNKNOWN French Group of Endocrine Tumors
May 26, 2004·Clinics in Laboratory Medicine·Nicole Massoll, Ernest L Mazzaferri
Dec 15, 2017·Histopathology·Julie Guilmette, Vania Nosé
May 3, 2005·Nature Reviews. Cancer·Stephen J Marx
Sep 27, 2008·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·H DralleK Lorenz
Jan 7, 2009·Current Opinion in Oncology·Sanziana RomanJulie Ann Sosa
May 11, 2005·Familial Cancer·Mariola Peczkowska, Andrzej Januszewicz
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·Marcia K PuñalesAna Luiza Maia
Mar 2, 2006·Journal of the National Cancer Institute·Francesca CarlomagnoMassimo Santoro
Sep 1, 2009·Expert Review of Endocrinology & Metabolism·Cornelis Jm LipsJo Wm Höppener
Jan 6, 2005·Endocrine Reviews·Stephen J Marx, William F Simonds
Dec 22, 2004·Arquivos brasileiros de endocrinologia e metabologia·Marcia K PuñalesAna Luiza Maia
Apr 22, 2006·Arquivos brasileiros de endocrinologia e metabologia·Marcelo A C G dos SantosSergio P de Almeida Toledo
Dec 12, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Stephen J Marx, David Goltzman
Apr 12, 2003·Langenbeck's Archives of Surgery·Andrea FrillingChristoph Erich Broelsch
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Volker F H BrauerChristian A Koch
Jan 31, 2006·Arquivos brasileiros de endocrinologia e metabologia·Ana Luiza MaiaMarcia Khaled Puñales
May 16, 2020·Frontiers in Endocrinology·Jes Sloth MathiesenMaria Rossing
Apr 5, 2021·Seminars in Cancer Biology·Jes Sloth MathiesenUlla Feldt-Rasmussen
Oct 13, 2021·Endocrine·Ali S AlzahraniHindi Al-Hindi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.